猫のワクチンの世界市場

猫のワクチンの世界市場は2030年までに17億米ドルに達する見込み

2024年に11億米ドルと推定された猫のワクチンの世界市場は、分析期間2024-2030年にCAGR 8.1％で成長し、2030年には17億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである改良/弱毒化生ワクチンは、CAGR 9.2%を記録し、分析期間終了時には9億6,510万米ドルに達すると予測されます。不活化ワクチン分野の成長率は分析期間中CAGR 7.2%と推定されます。

米国市場は推定2億9,080万米ドル、中国はCAGR12.8%で成長予測

米国の猫のワクチン市場は、2024年に2億9,080万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを12.8%として、2030年までに3億6,970万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.0%と7.8%と予測されています。欧州では、ドイツがCAGR 5.4%で成長すると予測されています。

世界の猫のワクチン市場- 主要動向と促進要因のまとめ

なぜ猫のワクチンの需要が増加しているのか？

ネコの健康に対する意識の高まりと、予防的な獣医療の普及が、猫のワクチンの需要を世界的に大きく押し上げています。ペットの飼育率が上昇を続ける中、猫白血病ウイルス（FeLV）、狂犬病、猫カリシウイルス（FCV）といった命に関わる病気からペットを守るため、定期的なワクチン接種を優先する飼い主が増えています。ペット業界における予防ヘルスケアへのシフトにより、ワクチンは猫のウェルネス・プランに不可欠な要素となっています。さらに、政府や非政府組織は、特に野良猫の個体数が多い地域で、ワクチン接種プログラムを積極的に推進しています。人獣共通感染症予防への注目が高まる中、規制当局はワクチンへのアクセスやコンプライアンスを広く確保するためのガイドラインを強化しています。このような努力は、伝染性のネコの病気の発生を予防するために、中核的なワクチン接種と非中核的なワクチン接種の重要性を強調する獣医師会によってさらにサポートされています。

獣医療の進歩は猫のワクチンにどのような影響を与えているか？

獣医学の分野ではワクチン開発が大きく進歩し、猫にとってより効果的で長持ちする予防接種の選択肢が増えつつあります。組換えDNA技術やベクターベースのワクチンは、猫用ワクチンの有効性と安全性を高め、副反応のリスクを低減し、より長期間の免疫を提供しています。このような技術革新により、複数のウイルス株や細菌に対する予防効果を向上させた新規ワクチンが開発されています。さらに、経鼻ワクチンや非アジュバントワクチンの導入により、注射部位反応に対する懸念が解消され、猫にとってより快適なワクチン接種が可能になりつつあります。免疫学の進歩はまた、猫の年齢、健康状態、ライフスタイルに合わせたワクチン接種を可能にし、個別化されたワクチン接種スケジュールへの道を開いた。獣医バイオテクノロジーの継続的な研究により、ワクチン製剤と送達方法の継続的な改善により、市場は恩恵を受けると予想されます。

猫のワクチンの採用を促進する市場動向とは？

猫用ワクチン市場を形成する主要動向のひとつは、混合ワクチンへの嗜好の高まりです。これらの製剤は、1回の投与で複数の疾患に対する免疫を提供するため、総合的な保護を確保しながら、何度も動物病院を受診する必要性を低減します。これらのワクチンに対する需要は、飼い猫に便利で費用対効果の高い予防接種オプションを求める飼い主の間で特に高いです。もうひとつの新たな動向は、ペット保険業者や動物病院が提供する予防獣医療パッケージの普及です。こうしたパッケージには、定期的なワクチン接種、診断検査、寄生虫駆除が含まれていることが多く、ワクチン摂取率の向上を促しています。さらに、ペットヘルスケア分野でのeコマースの浸透により、動物用ワクチンがより身近なものとなっており、オンラインプラットフォームが宅配や定期購入ベースのワクチンサービスを容易にしています。

猫のワクチン市場の主な成長促進要因は？

猫のワクチン市場の成長は、ペット飼育の増加、ワクチン技術の進歩、ネコ伝染病の有病率の上昇など、いくつかの要因によってもたらされます。また、特に新興市場における動物医療インフラの拡大も、質の高いワクチン接種サービスへのアクセスを改善することで市場成長に寄与しています。さらに、狂犬病ワクチン接種やその他の猫伝染病予防プログラムに対する規制の義務化が、ワクチン普及を後押ししています。ペットの福祉と責任ある飼養への関心の高まりは、定期的なワクチン接種の遵守率向上につながっています。さらに、ネコ特有の病気を対象とした研究イニシアチブの拡大により、今後数年間で、より効果的な新ワクチンの導入が見込まれています。獣医学が進化し続ける中、猫のワクチンはネコのヘルスケアに不可欠な要素であり続け、世界中の飼いネコと野良ネコの集団の幸福を確保します。

セグメント

ワクチンタイプ（改良/弱毒化生ワクチン、不活化ワクチン、その他のワクチンタイプ）、疾患（猫呼吸器疾患、猫白血病疾患、猫汎白血球減少症疾患、猫狂犬病疾患、その他の疾患）、投与経路（注射剤投与経路、経鼻投与経路）、免疫期間（1年免疫期間、3年免疫期間、その他の免疫期間）

調査対象企業の例

• Bioveta, a. s.
• Boehringer Ingelheim International GmbH
• Durvet Inc.
• Elanco Animal Health Incorporated
• Greencross Vets
• Indian Immunologicals Ltd.
• Mars, Inc.
• Medivet
• Merck Animal Health
• Petco Animal Supplies, Inc.
• The Vets Holding Inc.
• VIRBAC Animal Health India Private Ltd.
• Virbac SA
• Zoetis, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Cat Vaccines Market to Reach US$1.7 Billion by 2030

The global market for Cat Vaccines estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Modified / Attenuated Live Vaccines, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$965.1 Million by the end of the analysis period. Growth in the Inactivated Vaccines segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$290.8 Million While China is Forecast to Grow at 12.8% CAGR

The Cat Vaccines market in the U.S. is estimated at US$290.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$369.7 Million by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Cat Vaccines Market - Key Trends & Drivers Summarized

Why Is the Demand for Cat Vaccines Increasing?

The growing awareness of feline health and the increasing adoption of preventive veterinary care have significantly boosted the demand for cat vaccines worldwide. As pet ownership continues to rise, more cat owners are prioritizing regular vaccinations to protect their pets from life-threatening diseases such as feline leukemia virus (FeLV), rabies, and feline calicivirus (FCV). The shift toward preventative healthcare in the pet industry has made vaccines an essential component of feline wellness plans. Additionally, governmental and non-governmental organizations are actively promoting vaccination programs, particularly in regions with high stray cat populations. With an increased focus on zoonotic disease prevention, regulatory authorities are strengthening guidelines to ensure widespread vaccine accessibility and compliance. These efforts are further supported by veterinary associations emphasizing the importance of core and non-core vaccinations to prevent outbreaks of contagious feline diseases.

How Are Advancements in Veterinary Medicine Impacting Cat Vaccines?

The field of veterinary medicine is witnessing significant advancements in vaccine development, leading to more effective and long-lasting immunization options for cats. Recombinant DNA technology and vector-based vaccines are enhancing the efficacy and safety of feline vaccines, reducing the risk of adverse reactions while providing longer immunity. These innovations have led to the development of novel vaccines that offer improved protection against multiple strains of viruses and bacteria. Moreover, the introduction of intranasal and non-adjuvanted vaccines is addressing concerns over injection-site reactions, making vaccinations more comfortable for cats. Advances in immunology have also paved the way for personalized vaccination schedules, ensuring that feline vaccinations are tailored based on age, health status, and lifestyle factors. With ongoing research in veterinary biotechnology, the market is expected to benefit from continuous improvements in vaccine formulations and delivery methods.

What Market Trends Are Driving the Adoption of Cat Vaccines?

One of the major trends shaping the cat vaccine market is the increasing preference for combination vaccines. These formulations provide immunity against multiple diseases in a single dose, reducing the need for multiple veterinary visits while ensuring comprehensive protection. The demand for these vaccines is particularly high among pet owners who seek convenient and cost-effective immunization options for their cats. Another emerging trend is the rising adoption of preventive veterinary care packages offered by pet insurance providers and veterinary clinics. These packages often include routine vaccinations, diagnostic screenings, and parasite control measures, encouraging higher vaccine uptake. Additionally, the growing penetration of e-commerce in the pet healthcare sector is making veterinary vaccines more accessible, with online platforms facilitating home delivery and subscription-based vaccine services.

What Are the Key Growth Drivers in the Cat Vaccines Market?

The growth in the Cat Vaccines market is driven by several factors, including increasing pet ownership, advancements in vaccine technology, and the rising prevalence of feline infectious diseases. The expansion of veterinary healthcare infrastructure, particularly in emerging markets, is also contributing to market growth by improving access to high-quality vaccination services. Additionally, regulatory mandates for rabies vaccination and other feline disease prevention programs are fueling vaccine adoption. The growing focus on pet welfare and responsible pet ownership is leading to higher compliance rates for routine vaccinations. Furthermore, the expansion of research initiatives targeting feline-specific diseases is expected to introduce new and more effective vaccines in the coming years. As veterinary medicine continues to evolve, cat vaccines will remain a crucial component of feline healthcare, ensuring the well-being of domestic and stray cat populations globally.

SCOPE OF STUDY:

The report analyzes the Cat Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Vaccine Type (Modified/Attenuated Live Vaccines, Inactivated Vaccines, Other Vaccine Types); Disease (Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases, Other Diseases); Route of Administration (Injectables Route of Administration, Intranasal Route of Administration); Duration of Immunity (1 Year Duration of Immunity, 3 Years Duration of Immunity, Other Durations of Immunities)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Bioveta, a. s.
• Boehringer Ingelheim International GmbH
• Durvet Inc.
• Elanco Animal Health Incorporated
• Greencross Vets
• Indian Immunologicals Ltd.
• Mars, Inc.
• Medivet
• Merck Animal Health
• Petco Animal Supplies, Inc.
• The Vets Holding Inc.
• VIRBAC Animal Health India Private Ltd.
• Virbac SA
• Zoetis, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Cat Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Awareness of Preventive Veterinary Care Drives Demand for Core and Non-Core Cat Vaccines
  • Technological Advancements in Vaccine Formulations Strengthen Efficacy and Safety Profiles
  • Growth in Companion Animal Healthcare Spending Expands Addressable Market for Cat Immunization
  • Regulatory Approvals and Vaccination Guidelines Propel Standardized Vaccine Adoption
  • Partnerships Between Veterinary Clinics and Pharma Companies Enhance Distribution and Accessibility
  • Emergence of Combination Vaccines Reduces Clinic Visits and Boosts Market Penetration
  • Epidemiological Trends and Outbreaks Throw Spotlight on the Importance of Routine Vaccination
  • Increased Adoption of Indoor and Outdoor Cats Drives Market Demand for Broad-Spectrum Vaccines
  • Expansion of Mobile Veterinary Services and Clinics Sustains Vaccination Outreach in Remote Areas
  • Digital Health Records and Pet Health Apps Drive Compliance with Vaccination Schedules
  • Public-Private Initiatives for Animal Health Awareness Strengthen Market for Preventive Care
  • Innovation in Needle-Free and Oral Vaccine Delivery Enhances Compliance and Reduces Stress
  • Globalization of Veterinary Pharma Markets Expands Access to Advanced Immunization Protocols
  • Growth in Feline Adoption Rates from Shelters Boosts Initial Vaccine Uptake
  • Challenges in Vaccine Storage and Cold Chain Management Create Demand for Thermostable Formulations
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Cat Vaccines Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Cat Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Cat Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Cat Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Modified / Attenuated Live Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Modified / Attenuated Live Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Modified / Attenuated Live Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Inactivated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Inactivated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Inactivated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Vaccine Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Vaccine Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other Vaccine Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Intranasal Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Intranasal Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Intranasal Route of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Injectables Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Injectables Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Injectables Route of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for 1 Year Duration of Immunity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for 1 Year Duration of Immunity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for 1 Year Duration of Immunity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for 3 Years Duration of Immunity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for 3 Years Duration of Immunity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for 3 Years Duration of Immunity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Durations of Immunities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Durations of Immunities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Durations of Immunities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Feline Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Feline Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Feline Respiratory Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Feline Leukemia Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Feline Leukemia Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Feline Leukemia Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Feline Panleukopenia Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Feline Panleukopenia Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Feline Panleukopenia Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Feline Rabies Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Feline Rabies Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Feline Rabies Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• JAPAN
  • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• CHINA
  • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 80: China Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• EUROPE
  • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Cat Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Cat Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Cat Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• FRANCE
  • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 107: France Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• GERMANY
  • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 143: UK Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Cat Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Cat Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• INDIA
  • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 218: India Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Cat Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Cat Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Cat Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Cat Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
• AFRICA
  • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030

IV. COMPETITION